inflammatory bowel disease
| 4 min read
A strain of E. coli linked to Crohn’s disease produces a compound that triggers intestinal scarring, revealing a potential treatment path.
From signaling hunger to influencing mood, the vagus nerve keeps the gut and brain in sync.
| 5 min read
An ingestible pill uses bacteria and electronic components to transmit information as it passes through the digestive tract.
Available on Demand
Spatial biology platforms shed light on the cellular and molecular players underlying ulcerative colitis and Crohn’s disease.
| 10+ min read
Genetically engineered bacteria could help diagnose or monitor gut diseases.
Page 1 of 1 - 5 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Harnessing liver-on-a-chip models for drug safety
Discover how researchers leverage microphysiological systems in toxicology studies.
Enhancing bioanalytical studies with centralized data management
Learn how researchers can improve compliance and efficiency with advanced LIMS solutions.
Explained: How are metabolite biomarkers improving drug discovery and development?
By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
